The M2-muscarinic receptor inhibits the development of streptozotocin-induced neuropathy in mouse urinary bladder

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 1, 2010, Pages 239-248

  Pak, K J ^a   Ostrom, R S ^b   Matsui, M ^c   Ehlert, F J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Tokyo west Tokushukai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M2 RECEPTOR; STREPTOZOCIN; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; ANTINEOPLASTIC ANTIBIOTIC; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; ISOPRENALINE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CONTRACTION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERGLYCEMIA; MALE; MICTURITION DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; UROTHELIUM; ALGORITHM; ANIMAL; BODY WEIGHT; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROSTIMULATION; GENETICS; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; NEUROGENIC BLADDER; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-AGONISTS; ALGORITHMS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD GLUCOSE; BODY WEIGHT; ELECTRIC STIMULATION; HYPERGLYCEMIA; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; ORGAN SIZE; RECEPTOR, MUSCARINIC M2; STREPTOZOCIN; URINARY BLADDER, NEUROGENIC;

EID: 77957238677     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.169995     Document Type: Article

References (31)

1. Andersen JT and Bradley WE (1976) Abnormalities of bladder innervation in diabetes mellitus. Urology 7:442-448.
2. Andersson KE and Arner A (2004) Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84:935-986. (Pubitemid 38823771)
3. Benkó R, Lázá r Z, Pórszász R, Somogyi GT, and Barthó L (2003) Effect of experimental diabetes on cholinergic, purinergic and peptidergic motor responses of the isolated rat bladder to electrical field stimulation or capsaicin. Eur J Pharmacol 478:73-80.
4. Birder LA, Nealen ML, Kiss S, de Groat WC, Caterina MJ, Wang E, Apodaca G, and Kanai AJ (2002) Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 22:8063-8070. (Pubitemid 35379112)
5. Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141-162.
6. Braverman A, Legos J, Young W, Luthin G, and Ruggieri M (1999) M2 receptors in genito-urinary smooth muscle pathology. Life Sci 64:429-436. (Pubitemid 29066689)
7. Braverman AS, Luthin GR, and Ruggieri MR (1998) M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder. Am J Physiol 275:R1654-R1660.
8. Braverman AS and Ruggieri MR Sr (2003) Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2. Am J Physiol Regul Integr Comp Physiol 285:R701-R708.
9. Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2:45-53.
10. Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, and Chacko S (2009) Diabetic bladder dysfunction: current translational knowledge. J Urol 182:S18-S26.
11. de Groat WC and Yoshimura N (2001) Pharmacology of the lower urinary tract. Ann Rev Pharmacol Toxicol 41:691-721.
12. Ehlert FJ, Ahn S, Pak KJ, Park GJ, Sangnil MS, Tran JA, and Matsui M (2007) Neuronally released acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder. J Pharmacol Exp Ther 322:631-637.
13. Ehlert FJ, Griffin MT, Abe DM, Vo TH, Taketo MM, Manabe T, and Matsui M (2005) The M2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder. J Pharmacol Exp Ther 313:368-378.
14. Faerman I, Glocer L, Celener D, Jadzinsky M, Fox D, Maler M, and Alvarez E (1973) Autonomic nervous system and diabetes. Histological and histochemical study of the autonomic nerve fibers of the urinary bladder in diabetic patients. Diabetes 22:225-237.
15. Freeman R (2005) Autonomic peripheral neuropathy. The Lancet 365:1259-1270.
16. Giglio D, Delbro DS, and Tobin G (2005) Postjunctional modulation by muscarinic M2 receptors of responses to electrical field stimulation of rat detrusor muscle preparations. Auton Autacoid Pharmacol 25:113-120.
17. Gür S and Cinel I (2003) Sodium selenate partially corrects impaired functional responses in detrusor muscle in streptozotocin-induced diabetic rats. Biol Trace Elem Res 93:171-188. (Pubitemid 36920877)
18. Ito Y, Oyunzul L, Seki M, Fujino Oki T, Matsui M, and Yamada S (2009) Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice. Br J Pharmacol 156:1147-1153.
19. Liu G and Daneshgari F (2005) Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes. Am J Physiol Renal Physiol 288:F1220-F1226. (Pubitemid 40677092)
20. Liu S-H and Lin-Shiau SY (1996) The effects of uranyl ions on neuromuscular transmission in the urinary bladder of the normal and streptozotocin-diabetic mouse. Naunyn Schmiedebergs Arch Pharmacol 354:773-778.
21. Longhurst PA, Levendusky MC, and Bezuijen MW (2004) Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction. J Urol 171:933-937.
22. Luheshi GN and Zar MA (1991) The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder. Br J Pharmacol 103:1657-1662.
23. Matsui M, Griffin MT, Shehnaz D, Taketo MM, and Ehlert FJ (2003) Increased relaxant action of forskolin and isoproterenol against muscarinic agonist-induced contractions in smooth muscle from M2 receptor knockout mice. J Pharmacol Exp Ther 305:106-113.
24. Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T, and Taketo MM (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22:10627-10632.
25. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, and Taketo MM (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 97:9579-9584.
26. Michel MC and Barendrecht MM (2008) Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Pharmacol Ther 117:297-312.
27. Pak KJ, Ostrom RS, Matsui M, and Ehlert FJ (2010) Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder. Naunyn Schmiedebergs Arch Pharmacol 381:441-454.
28. Sibley GN (1984) A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol 354:431-443.
29. Stengel PW, Yamada M, Wess J, and Cohen ML (2002) M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 282:R1443-R1449.
30. Tesch GH and Allen TJ (2007) Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology 12:261-266.
31. Tesch GH and Nikolic-Paterson DJ (2006) Recent insights into experimental mouse models of diabetic nephropathy. Nephron Exp Nephrol 104:e57-62.